Healthcare Web Wire

Author: Elena Morales

Bone Grafts and Substitutes Market Overview
Bone Grafts and Substitutes Market Size, Segments and Insights

The global market for bone grafts and substitutes was valued at approximately US$ 2.99 billion in 2023. It is expected to grow significantly, reaching an estimated US$ 5.95 billion by 2034, with a compound annual growth rate (CAGR) of 6.45% from 2024 to 2034.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5227

Here are the key insights rephrased
- In 2023, North America held the largest market share at 43%.
- The Asia Pacific region is expected to grow the fastest, with a projected growth rate of 6.04% during the forecast period.
- The allograft material segment was the largest in 2023, accounting for 57% of the market.
- The synthetic material segment is anticipated to grow at the fastest rate from 2024 to 2034.
- The spine fusion application was the leading segment in the bone grafts and substitutes market in 2023.
- The dental application is expected to experience the fastest growth during the forecast period.
Leading Companies in the Bone Grafts and Substitutes Market
- AlloSource: A nonprofit organization specializing in providing human tissue allografts for medical use, including bone grafts and substitutes.
- Biogennix: Known for its advanced biomaterial solutions in bone grafting, Biogennix develops synthetic and regenerative bone substitutes.
- OST Laboratories: Specializes in providing bone grafting solutions, focusing on the research and development of innovative technologies.
- Biobank: A leading provider of human tissue-based products, offering a wide range of bone grafts for various medical applications.
- Paradigm BioDevices, Inc.: Focuses on developing advanced bioresorbable implants and substitutes for bone grafting, improving healing processes.
- Smith + Nephew: A global medical technology company, Smith + Nephew provides bone grafts, joint reconstruction, and wound care products.
- NuVasive, Inc.: Specializes in minimally invasive spine surgery technologies and bone graft products designed to support spinal fusion procedures.
- DePuy Synthes (Johnson & Johnson Inc.): A leader in the orthopedic and spinal market, DePuy Synthes offers a broad portfolio of bone grafts, including synthetic and biologic options.
- TBF: A company that focuses on providing high-quality bone graft substitutes and materials for a range of orthopedic applications.
- Orthofix US LLC: Known for its orthopedic and spinal solutions, Orthofix offers bone graft substitutes and medical devices for bone healing.
- Baxter: A global healthcare company providing a variety of medical products, including bone grafts, with a focus on regenerative medicine.
- Stryker: A major player in the medical technology field, Stryker offers a wide range of orthopedic and bone grafting products, including those for joint and spine surgery.
- Zimmer Biomet: A leading global company in musculoskeletal healthcare, Zimmer Biomet develops bone grafts and substitutes to support joint and spine health.
- Medtronic: Known for its medical technologies, Medtronic offers a variety of orthopedic solutions, including bone graft products for spinal and trauma procedures.
- Geistlich Pharma AG: Specializes in regenerative medicine, particularly in bone graft substitutes, providing high-quality biomaterials for dental and orthopedic applications.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/bone-grafts-and-substitutes-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5227

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
December 5, 2024
Cell Cryopreservation Market Key Players and Growth Insights
Cell Cryopreservation Market Growth and Trends

The global cell cryopreservation market is valued at $11.48 billion in 2024 and is projected to reach $77.52 billion by 2034, growing at a CAGR of 21.05%. The increasing demand for cell cryopreservation in healthcare applications, driven by ongoing research, is fueling this growth.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5361

Cell Cryopreservation Market Overview

Cryopreservation is a process used to preserve cells by keeping biological material in a suspended state at freezing temperatures for long periods. This technique is crucial in various medical and pharmaceutical applications, including preserving hematopoietic tissue for transplantation and storing pluripotent stem cells for in vitro fertilization. Cryopreservation plays a significant role in the development of biologics, such as vaccines, by preserving cell lines. It is also vital for biotechnology, clinical testing, and research, as well as for targeted therapies like autologous stem cell therapy, which involves freezing stem cells (e.g., those taken from bone marrow) for future use.

Top Companies in the Cell Cryopreservation Market
- Thermo Fisher Scientific Inc.
  Thermo Fisher is a global leader in scientific research and laboratory supplies. They offer a range of cell cryopreservation products, including cryopreservation media, systems, and solutions, supporting industries like pharmaceuticals, biotechnology, and healthcare.
- Merck KGaA
  Merck KGaA provides cryopreservation solutions through their life sciences division, offering high-quality media and reagents designed to maintain the viability of cells during freezing and thawing processes. Their products cater to research, clinical applications, and regenerative medicine.
- Sartorius AG
  Sartorius specializes in bioprocess solutions, providing cutting-edge cryopreservation technologies for the biotechnology and pharmaceutical industries. Their portfolio includes cryoprotectants and cryopreservation equipment designed for the preservation of stem cells, cell cultures, and biological materials.
- PromoCell GmbH
  PromoCell focuses on providing cell-based research products, including cryopreservation solutions for preserving primary cells and cell lines. Their offerings are widely used in academic research and drug development.
- Lonza
  Lonza is a global leader in life sciences, offering comprehensive cryopreservation services, including media and solutions for stem cells, immune cells, and other biological materials. They support cell therapy, regenerative medicine, and drug discovery.
- HiMedia Laboratories
  HiMedia Laboratories offers a wide range of cryopreservation products, including specialized media and reagents for cell storage. Their solutions are used in microbiology, biotechnology, and clinical research applications.
- Creative Biolabs
  Creative Biolabs provides a range of cryopreservation services, including custom solutions for preserving various cell types. Their services support the biotechnology and pharmaceutical industries, focusing on research, cell therapy, and regenerative medicine.
- Corning Incorporated
  Corning provides innovative cell culture and cryopreservation products, including vials, media, and cryoprotectants. Their solutions support a wide range of applications in pharmaceutical development, biomanufacturing, and clinical research.
- BioLife Solutions Inc.
  BioLife Solutions offers high-performance cryopreservation media and related products for cell and tissue preservation. Their products are widely used in the biopharmaceutical and cell therapy sectors, providing essential tools for maintaining cell viability and integrity during freezing and storage.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/cell-cryopreservation-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5361

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
December 5, 2024
Virus Filtration Market Trends, Insights and Growth Forecast

Virus Filtration Market Overview

The global virus filtration market is expected to grow from USD 5.22 billion in 2024 to USD 5.75 billion in 2025, reaching around USD 13.7 billion by 2034, with a CAGR of 10.5%. The market’s growth is driven by the expanding biotechnology sector, increased biotech product manufacturing, and technological advancements.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5360

Virus Filtration Market Essential Protection for Biotech Products

Virus filtration is a critical and efficient technology used to remove viruses from biological products during manufacturing. Biological therapeutics, especially those made from mammalian cell lines or human plasma, are at risk of contamination by known or unknown viruses. To ensure safety, regulatory authorities require the use of virus filters in the production process. These filters play a vital role in preventing harmful viruses from contaminating important medications. By filtering viruses based on size, they are key to ensuring viral safety in the production of biological products.

The rapid growth of the global biotechnology sector, driven by increased investments and partnerships, is fueling the demand for virus filtration. As the production of biological therapeutics rises, the need for effective virus filtration solutions also grows. Stricter regulatory standards for virus removal during manufacturing further drive the market for these filtration technologies.

Segmental Insights

Consumables Segment Leads the Market
In 2023, the consumables segment was the largest in the virus filtration market. Consumables, including kits, filters, filter holders, reagents, and other components, are essential for the virus filtration system’s operation. They ensure product safety, regulatory compliance, and efficient processing. The availability of consumables allows companies to purchase only the necessary parts, reducing the overall cost compared to buying a complete filtration system.

Services Segment: Fastest-Growing
The services segment is expected to experience the highest growth rate in the virus filtration market during the forecast period. Many companies now offer virus filtration services for biopharmaceutical production, vaccine manufacturing, and plasma-based products. These services specialize in removing viruses from biological products, ensuring their safety for use.

Filtration Segment Dominates Technology
In 2023, the filtration segment was the leading technology in the virus filtration market. Nanofiltration is the most common method used, as it effectively separates both enveloped and non-enveloped viruses. Innovations in filtration technology, including filters with smaller mesh sizes to capture even tiny viruses, are contributing to the segment’s growth. New membrane filters based on direct flow filtration (DFF) are also advancing the technology.

Chromatography Segment: Fastest Growth in Technology
The chromatography segment is expected to grow at the fastest rate in the virus filtration market. Chromatography plays a crucial role in viral vector purification, particularly in large-scale GMP (Good Manufacturing Practice) processes, such as for advanced therapies, vaccines, and cell and gene therapies. Technological advancements are driving innovation in this technique.

Biologicals Segment Led in 2023
The biologicals segment was the largest application in the virus filtration market in 2023. With the increasing demand for biological products like monoclonal antibodies, vaccines, blood products, and cell and gene therapies, this segment is growing rapidly. The support of regulatory frameworks for biological products and the rising prevalence of chronic diseases are key factors driving market growth. Biologicals are used to treat a variety of chronic conditions, including autoimmune, inflammatory, and hematological disorders, by stimulating or restoring immune system functions.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/virus-filtration-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5360

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

December 5, 2024
Healthcare IT Market Trends and Key Developments
Healthcare IT Market Growth and Trends

The healthcare IT market, valued at $238.30 billion in 2023, is projected to reach $1,404.55 billion by 2034, growing at a 17.5% CAGR. Rising health challenges and data demands make IT integration essential for efficient healthcare management.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5220

Key Highlights of the Healthcare IT Market
- North America led the market in 2023, accounting for 41% of the total market share.
- The Asia Pacific region is anticipated to experience the fastest growth during the forecast period.
- Among types, healthcare provider solutions emerged as the largest segment in 2023.
- Healthcare providers were the primary end-users, dominating the market in 2023.
Latest Announcements and Developments in the Healthcare IT Market

Industry Insights
Deepak Sahni, CEO of Healthians, recently shared his views on the growing role of artificial intelligence (AI) in transforming healthcare. According to Sahni, AI plays a significant role in enhancing diagnostic processes, enabling continuous monitoring of patients, and providing valuable data-driven insights. This technology is helping to decentralize healthcare services, allowing for more personalized and proactive care interventions that can improve patient outcomes.

Recent Developments
- Government Initiative on Central Registry (September 2024): In a major step towards improving healthcare standards, the Union government of India plans to establish a central registry for medical practitioners. This move will help in building a comprehensive national database of certified healthcare professionals, particularly those working in allied healthcare fields. The National Commission of Allied and Healthcare Professionals (NCAHP) Act 2021, which supports this initiative, is expected to be implemented by October 2024 at the latest, as per the directive from the Supreme Court of India. This central registry is part of the government’s broader efforts to regulate and professionalize the healthcare workforce.
- WHO’s AI-Powered Health Assistant – S.A.R.A.H. (April 2024): The World Health Organization (WHO) unveiled S.A.R.A.H. (Smart AI Resource Assistant for Health), an innovative digital health promoter powered by generative AI. This AI-driven health assistant is designed to assist individuals with health-related information and is capable of interacting in eight different languages. It operates 24/7 and is accessible on various devices, providing people with timely and accurate health guidance. The introduction of S.A.R.A.H. highlights the WHO’s commitment to leveraging AI to improve healthcare accessibility and information dissemination globally.
- Digital Training Program for Healthcare Workers (March 2024): To support the ongoing digital transformation of India’s healthcare sector, UNICEF India, in collaboration with the International Institute of Health Management Research (IIHMR), New Delhi, and IIT Bombay, launched a digital course aimed at upskilling healthcare workers. This program is designed to equip professionals with the necessary skills to navigate the increasing use of technology in healthcare, ensuring they are well-prepared to lead digital healthcare initiatives in the country. This development is part of broader efforts to modernize the healthcare workforce and improve the delivery of healthcare services through digital solutions.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/healthcare-it-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5220

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
December 5, 2024
3D Cell Culture Market Trends and Growth Outlook
3D Cell Culture Market Growth Key Insights

The global 3D cell culture market, valued at USD 2.10 billion in 2023, is projected to reach USD 7.02 billion by 2034, growing at a CAGR of 11.6%. Advancements in spheroid and organoid research are driving this expansion.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5201
Key Highlights of the 3D Cell Culture Market

North America led the market in 2023, accounting for 42.01% of the global share.

The Asia-Pacific region is projected to experience the fastest growth during the forecast period.

Among technologies, scaffold-based methods dominated the market in 2023, while scaffold-free methods are expected to grow the quickest.

In applications, stem cell research and tissue engineering represented the largest market share in 2023, with cancer research poised for the fastest growth.

Biopharmaceutical and pharmaceutical companies were the top end-users in 2023, but academic and research institutions are set to grow at the fastest rate.

3D Cell Culture Market Trends

Expanding Research and Development Efforts: The increasing need for innovative drug discovery and advancements in stem cell research are key drivers of the 3D cell culture market. These activities aim to improve understanding of disease mechanisms and enhance treatment outcomes.

Rising Prevalence of Chronic Disorders: The growing burden of chronic illnesses such as cancer, autoimmune diseases, and neurological disorders is fueling demand for effective treatments. This surge in R&D for targeted therapies supports the adoption of 3D cell culture techniques.

Boost in Investments: Governments and private organizations worldwide are allocating substantial funding to research institutions to accelerate advancements in 3D cell culture technologies. These investments enable cutting-edge studies and infrastructure development.

Advancements in Technology: Emerging technologies like artificial intelligence (AI) and machine learning (ML) are revolutionizing the 3D cell culture landscape. These tools enhance the efficiency, precision, and scalability of research processes, driving innovation in drug development and tissue engineering.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/3d-cell-culture-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5201

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
December 5, 2024
Carpal Tunnel Syndrome Market Trends and Forecast (2024 – 2034)
Carpal Tunnel Syndrome Market Size, Trends and Growth Outlook (2024 – 2034)

The global market for Carpal Tunnel Syndrome (CTS) is valued at approximately USD 977.57 million in 2024. It is projected to reach USD 1,405.80 million by 2034, growing at a compound annual growth rate (CAGR) of 3.7% over the next decade.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5138

Report Highlights
- In 2023, integrative therapy held a notable 38% share of the market.
- NSAIDs were the most commonly used treatments in 2023.
- North America represented the largest market share, with 32% in 2023.
- Certain job types can increase the risk of Carpal Tunnel Syndrome. According to the US Department of Labor, for every 10,000 workers, around 0.5 develop Carpal Tunnel Syndrome due to their work.
Carpal Tunnel Syndrome is responsible for 90% of all cases of neuropathy, making it the most common type of focal mononeuropathy. This condition is caused by the compression of the median nerve as it passes through the carpal tunnel. The initial symptoms include pain, numbness, and a tingling sensation along the median nerve. If left untreated or misdiagnosed, Carpal Tunnel Syndrome can lead to permanent loss of hand function and sensation. This report explores the causes, symptoms, diagnostic methods, and treatment options for Carpal Tunnel Syndrome, highlighting the importance of a collaborative approach by healthcare teams in managing the condition.

Carpal Tunnel Syndrome Market Trends

The Carpal Tunnel Syndrome (CTS) market is witnessing notable trends driven by advancements in treatment options and growing awareness of the condition. Here are some key trends shaping the market:
- Rising Prevalence: An increase in the number of people diagnosed with CTS is expected, largely due to lifestyle changes, prolonged use of digital devices, and repetitive work tasks that strain the wrists.
- Advancements in Treatment: There is a growing preference for minimally invasive treatments, such as endoscopic surgery and non-surgical options like corticosteroid injections, splints, and physical therapy.
- Integrative Therapies: Integrative and alternative therapies, including acupuncture and chiropractic care, are gaining traction. These methods are increasingly being used alongside traditional medical treatments for better management of symptoms.
- Technological Integration: Wearable devices and mobile health apps designed to monitor symptoms and aid in rehabilitation are becoming more prevalent, offering patients personalized treatment options and real-time feedback.
- Increased Awareness: With more focus on work-related injuries, there is greater awareness about CTS, leading to earlier detection and intervention. Organizations are also implementing ergonomic solutions to reduce the risk of CTS in the workplace.
- Focus on Early Diagnosis: Early identification through diagnostic tests, such as nerve conduction studies and electromyography, is crucial in preventing the progression of the disease, leading to a shift towards preventive healthcare measures.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/carpal-tunnel-syndrome-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5138

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
December 4, 2024
Recent Announcements and Developments in the 3D Cell Culture Market
3D Cell Culture Market Growth, and Regional Insights

The global 3D cell culture market was valued at $2.10 billion in 2023 and is expected to reach $7.02 billion by 2034, growing at a compound annual growth rate (CAGR) of 11.6% from 2024 to 2034. This growth is primarily driven by increasing research and advancements in spheroids and organoids.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5201

Key Insights of the 3D Cell Culture Market

Regional Insights: North America held the largest share of the 3D cell culture market, accounting for 42.01% in 2023. However, the Asia Pacific region is expected to experience the fastest growth during the forecast period.

Technology Trends: The scaffold-based technology segment led the market in 2023. Meanwhile, the scaffold-free segment is anticipated to grow at the fastest rate over the forecast period.

Application Insights: The stem cell research and tissue engineering segment dominated the market in 2023. The cancer research segment is expected to grow the fastest during the forecast period.

End-Use Insights: Biopharmaceutical and pharmaceutical companies held the largest share of the 3D cell culture market in 2023. However, academic and research institutes are projected to see the fastest growth during the forecast period.

Recent Announcements from Industry Leaders

Eric Perreault has been appointed as the new CEO of Kiyatec, Inc., a biotechnology company specializing in 3D cell culture technology. He aims to lead the company in transforming cancer care, particularly for brain cancer patients, by leveraging 3D cell culture technology to enhance patient outcomes.

Recent Developments in the 3D Cell Culture Market

In August 2024, Cell Microsystems, a leader in innovative cell biology instruments, expanded its contract research lab services. Utilizing their advanced CellRaft® Technology, the services now include generating cell lines, custom organoids, and conducting various tests.

In June 2024, Predictive Oncology, a company focused on biologics and drug discovery, introduced a new 3D cell culture model to accelerate cancer treatment development. The company has developed in vitro organ and disease-specific models that accurately replicate human tissue’s physiological conditions.

In June 2023, ioFibR, a tissue engineering innovator based in Halifax, Nova Scotia, launched two new collagen fiber products: CollaFibRTM 3D scaffold and μCollaFibRTM (micro-CollaFibRTM). These products, created using ioFibR’s unique dry-spinning technique, offer significant advantages for tissue engineering and culture applications.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/3d-cell-culture-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5201

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
December 4, 2024
Healthcare IT Market Analysis Key Trends and Leading Companies
Healthcare IT Market Growth Trends and Future Outlook

The global healthcare IT market was valued at $238.30 billion in 2023 and is projected to grow to $1,404.55 billion by 2034, with a compound annual growth rate (CAGR) of 17.5% from 2024 to 2034. As the global population continues to grow and healthcare challenges increase, the volume of data generated also rises. Information technology (IT) is becoming essential in effectively managing this data, driving the need for its integration into healthcare systems.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5220

Key Insights into the Healthcare IT Market
- North America held the largest share of the healthcare IT market, accounting for 41% in 2023.
- Asia Pacific is expected to experience the fastest growth during the forecast period.
- In terms of market share, the healthcare provider solutions segment was the largest in 2023.
- The healthcare providers segment was the dominant end-user of healthcare IT services in 2023.
Leading Companies in the Healthcare IT Market

Accenture
A global consulting firm, Accenture offers a wide range of IT solutions, including healthcare-specific services to improve operational efficiency and patient care. Their healthcare IT services include cloud computing, data analytics, and digital transformation.

eMDs, Inc.
eMDs provides electronic health record (EHR) solutions and other healthcare software to streamline clinical workflows. They focus on improving practice management and patient engagement for healthcare providers.

McKesson Corporation
McKesson is one of the largest healthcare distributors in the world, offering IT solutions like electronic health record systems, pharmacy automation, and data analytics to improve patient care and supply chain management.

Novarad
Specializing in radiology information systems (RIS) and picture archiving and communication systems (PACS), Novarad provides innovative IT solutions to help healthcare providers manage medical imaging and patient data effectively.

Hewlett Packard Enterprise (HPE)
HPE provides healthcare IT solutions focused on data storage, cloud computing, and IT infrastructure. Their technologies help healthcare organizations manage large datasets and support patient care systems.

Athenahealth, Inc.
Athenahealth offers cloud-based healthcare IT solutions, including EHR, practice management, and medical billing software. Their platform enables providers to improve efficiency and enhance patient experiences.

Veradigm Inc.
Veradigm is a healthcare IT company that provides solutions for electronic health records, data analytics, and patient engagement. They aim to improve clinical workflows and health outcomes through technology.

Agfa-Gevaert Group
Agfa-Gevaert specializes in imaging technologies, offering software and IT solutions for medical imaging, diagnostics, and healthcare workflow management. Their solutions help optimize radiology and medical imaging departments.

GE Healthcare
GE Healthcare is a leader in medical technology, offering healthcare IT solutions for imaging, diagnostics, and data management. Their platforms help healthcare organizations manage patient data and improve care delivery.

Carestream Health
Carestream provides digital imaging solutions and healthcare IT software, including cloud-based platforms for managing medical images and patient information, helping healthcare providers improve diagnostic accuracy.

IBM
IBM offers advanced AI, cloud computing, and data analytics solutions for the healthcare industry. Their Watson Health division focuses on using AI to improve patient care and enhance clinical decision-making.

Oracle
Oracle provides enterprise cloud solutions for healthcare organizations, including electronic health records, patient data management, and analytics. Their software helps streamline operations and improve healthcare outcomes.

IQVIA
IQVIA offers data analytics and technology solutions to the healthcare industry, focusing on improving clinical trials, patient engagement, and research outcomes using big data and advanced analytics.

SAP
SAP offers enterprise resource planning (ERP) and healthcare IT solutions designed to help healthcare organizations manage operations, improve patient care, and enhance financial performance through integrated systems.

Verisk Analytics, Inc.
Verisk Analytics provides data analytics solutions for the healthcare industry, offering insights into healthcare trends, claims, and risk management to improve operational efficiencies and patient outcomes.

SAS Institute, Inc.
SAS Institute offers analytics and AI-driven solutions to the healthcare sector. Their software helps healthcare providers optimize operations, manage patient data, and predict patient outcomes.

Philips Healthcare
Philips Healthcare provides healthcare IT solutions focused on imaging, diagnostics, and patient monitoring. Their technologies help healthcare providers improve patient care and clinical efficiency.

Optum, Inc.
A part of UnitedHealth Group, Optum offers healthcare IT services, including data analytics, pharmacy management, and healthcare services. They work to enhance the quality and efficiency of care while reducing costs.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/healthcare-it-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5220

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
December 4, 2024
Virus Filtration Market Key Players and Growth Insights
Growth Opportunities and Innovations in the Virus Filtration Market
The global virus filtration market is valued at approximately USD 5.22 billion in 2024 and is expected to grow to USD 5.75 billion by 2025. By 2034, the market is projected to reach around USD 13.7 billion, reflecting a robust compound annual growth rate (CAGR) of 10.5% from 2024 to 2034. This growth is fueled by the rapidly evolving biotechnology sector, increased production of biotech products, and continuous technological advancements in filtration techniques.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5360

Virus Filtration Market: Ensuring Safety in Biologics Production

Virus filtration is a critical technology for ensuring virus clearance, widely used in the production of biological therapeutics. Products manufactured using mammalian cell lines or human plasma are vulnerable to contamination by both known and unknown viruses. To address this risk, regulatory authorities require the integration of virus filtration in the manufacturing process. These filters, designed to separate viruses based on size, play a pivotal role in safeguarding biologics from contamination during downstream processing.

As the global biotechnology sector grows, fueled by increasing investments and strategic collaborations, the demand for virus filtration technologies is rising. The expanding production of biologics as therapeutic solutions further propels this market. Additionally, stringent regulatory requirements for virus removal during manufacturing drive the adoption of virus filtration systems, underscoring their importance in maintaining safety and quality standards.

Leading Players in the Virus Filtration Market

The virus filtration market is dominated by several key companies, each contributing significantly to innovation and growth in the sector:

3M: Renowned for its advanced filtration technologies, 3M provides solutions that enhance viral safety in biologics manufacturing.

Asahi Kasei Medical Co. Ltd.: A global leader in virus removal filters, offering products tailored for efficient downstream processing in biologics.

Charles River Laboratories International, Inc.: Specializes in comprehensive biopharmaceutical testing services, including virus filtration validation.

Clean Cell, Inc.: Provides virus clearance testing and filtration solutions to ensure safety in pharmaceutical processes.

Cytiva Lifesciences: A Danaher company known for its robust filtration systems designed for biomanufacturing applications.

Danaher Corporation: Drives innovation through its subsidiaries like Cytiva, delivering advanced filtration technologies.

Merck KGaA: Offers high-performance virus filtration systems as part of its life science solutions portfolio.

Parexel: Focuses on biopharmaceutical services, including virus clearance strategies to meet regulatory requirements.

Qiagen: Provides sample preparation and purification technologies, enhancing viral safety in biotech workflows.

Sartorius AG: A leading provider of filtration equipment, Sartorius supports scalable solutions for biologics production.

Sigma Aldrich: Part of Merck, offering a wide range of products for virus filtration in research and manufacturing.

TeraPore Technologies: Innovates in high-selectivity filtration materials for efficient virus removal.

Wuxi Biologics: Provides integrated services, including virus filtration, to streamline biologics development and manufacturing.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/virus-filtration-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5360

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
December 4, 2024
Innovations Driving the Cell Cryopreservation Market

Cell Cryopreservation Market Size, Trends and Future Growth

The global cell cryopreservation market is estimated at USD 11.48 billion in 2024 and is forecasted to grow to USD 13.89 billion by 2025. By 2034, the market is projected to reach approximately USD 77.52 billion, showcasing a robust compound annual growth rate (CAGR) of 21.05% over the forecast period.

Cell cryopreservation is increasingly vital in various healthcare applications, driving strong market demand. With continuous advancements in medical research, the need for reliable cell preservation technologies is anticipated to surge significantly in the coming years.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5361

Cell Cryopreservation Market Overview

Cryopreservation is a vital technique used to maintain the integrity of cells by storing biological material at freezing temperatures, effectively putting it in a state of suspended animation for long-term preservation. This method is widely used in various pharmaceutical applications, including preserving hematopoietic tissue for transplants and pluripotent stem cells for in vitro fertilization.

The field of cryobiology has greatly contributed to advancements in medicine, particularly in the development of biologics like vaccines, by enabling the long-term storage of cell lines. Cryopreservation also plays a critical role in biotechnology, clinical testing, and research. It supports innovative therapies, such as autologous stem cell treatments, by preserving essential cells like those extracted from bone marrow for future use.

Cell Cryopreservation Market Trends

The cell cryopreservation market is witnessing significant investment and innovation. In June 2024, Acorn Biolabs, a Toronto-based biotechnology company specializing in stem cell freezing for regenerative medicine therapies, announced a Series A funding round of $11 million CAD (approximately $8 million USD). This funding, raised through multiple closings, highlights growing confidence in cell preservation technologies.

Similarly, in March 2024, CryoLogyx, a spinout from the University of Warwick, completed an oversubscribed seed funding round. The company, which aims to revolutionize cell science through cryopreservation, secured £500,000 GBP from the Wider Oxford Technology Angel Network (WOTAN), supported by investors like Oxford Technology Management and private UK business angels. These developments underscore the market’s dynamic growth and the increasing interest in cryopreservation innovation.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/cell-cryopreservation-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5361

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

December 4, 2024